Scientific Briefing: Landscape of phage display in therapeutic antibody discovery

Landscape of phage display in therapeutic antibody discovery

Phage display technology has advanced significantly since its development in the late 1980s, and it remains a powerful platform for generating therapeutic and bioanalytical antibodies. More recently, it has gained increasing interest. In this scientific briefing, Dr. Francisco Ylera, Head of R&D at Bio-Rad Laboratories, will review the key advantages of antibody phage display and discuss how this technology enables the discovery of highly specific, high-affinity, functional antibody candidates. He will explore its applications across academic research and modern preclinical discovery in the biopharmaceutical industry.